Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery
Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...
Saved in:
Main Author: | |
---|---|
Contributors: | |
Format: | Doctoral Thesis |
Language: | English |
Published: |
Philipps-Universität Marburg
2019
|
Subjects: | |
Online Access: | PDF Full Text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
PDF Full TextCall Number: |
urn:nbn:de:hebis:04-z2019-05018 |
---|---|
Publication Date: |
2020-05-25 |
Date of Acceptance: |
2019-09-12 |
Downloads: |
185 (2024), 149 (2023), 183 (2022), 158 (2021), 49 (2020) |
License: |
https://rightsstatements.org/vocab/InC-NC/1.0/ |
Access URL: |
https://archiv.ub.uni-marburg.de/diss/z2019/0501 https://doi.org/10.17192/z2019.0501 |